Capstan Medical, a developer of robotic enabled minimally invasive solutions to address heart valve disease, announced today its $110 million Series C to further advance its mission of bringing its innovative structural heart solution to patients.
The round was led by Eclipse, with participation from existing investors Yu Galaxy and Intuitive Ventures, and new investment from Gideon Strategic Partners.
Heart disease has remained the leading cause of death in America for over 100 years, claiming a life every 33 seconds. Today, there are more than 7 million people in the US with heart valve disease, a complex condition made up primarily of mitral and tricuspid valve disease. [Read more…] about Surgical robotics startup Capstan Medical raises $110 million in new funding